QIAGEN has introduced QCI Secondary Analysis a cloudbased softwareasaservice solution that facilitates highthroughput secondary analysis for clinical nextgeneration sequencing
ImmunityBio Inc recently announced an exclusive global collaboration with the Serum Institute of India the worlds largest vaccine manufacturer in terms of doses produced This partnership
Galecto Inc a biotech company specializing in pioneering cancer and fibrosis treatments has reached a significant milestone in its clinical journey Theyve initiated an investigatorled Phase trial at the Earle A
Aileron Therapeutics Inc a biopharmaceutical company focused on developing treatments for orphan pulmonary and fibrosis conditions has shared encouraging results from Cohort of its Phase b clinical trial
ONO Pharmaceutical Co Ltd with Gyo Sagara as Representative Director Chairman of the Board and Chief Executive Officer and Deciphera Pharmaceuticals Inc led by Chief Executive Officer Steven L Hoerter have announced a definitive merger agreement
Soleno Therapeutics Inc has announced that the US Food and Drug Administration granted Breakthrough Therapy Designation to diazoxide choline for the treatment of adults and children aged
Curiox Biosystems Co Ltd a leader in the innovation of life science research technologies and Beckman
Akoya Biosciences Inc The Spatial Biology Company and Shanghai KR Pharmtech a leading company
Guangzhou Biogene Technologies a biotechnology company engaged in the discovery development and delivery of novel cell therapies for the treatment of blood malignancies and solid tumors
Pluri Inc a leading biotechnology company that transforms cells into solutions today launched its placental allogeneic MAIT cell platform for immunotherapy
Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced the availability of Evercode BCR and the expansion of its existing Evercode TCR product line The new BCR solution and updates to the existing TCR product line expand Parses single cell po...
Shenzhen Chipscreen Biosciences Co Ltd announced that the companys lead innovative product
Chicago, Illinois, USA
Arizona,USA
Boston, MA, USA
Dubai, United Arab Emirates
London, UK
Maharashtra, India
Maharashtra, India
Co-Founder and CTO, Aventior, Inc
Assistant Professor, SRM University
Department of Biotechnology, Deenbandhu Choturam University
Department of Biotechnology, Royal Global University
Department of Zoology, Gauhati University
Department of Pharmacology, Senghundhar College of Pharmacy, The Tamilnadu Dr. M.G.R Medical University
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Doctoral Research Scholar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner LygatureHomeopathy a controversial medical system discovered by a German physician Samuel Hahnemann was first postulated at the end of the th century and mentioned in the first edition of his Organon in In such anecdotal times where theories about the deficiency four bodily fluids theories about corrupted juices were propagating against all odds the beginning of prescientific medical theories were bo...
The COVID outbreak has posed an unprecedented challenge to humanity and science On the one side public and private incentives have been put in place to promptly allocate resources toward research areas strictly related to the COVID emergency However research in many fields not directly related to the pandemic has been displaced In this paper we assess
IntroductionXceleron is a world leader in the use of Accelerator Mass Spectrometry AMS analytical technology in pharmaceutical food technology crop protection and biobased product applicationsOur primary business is in pharmaceutical research and development Since we have been helping to design preclinical and clinical investigations around the
Aegis Therapeutics announced that it has developed a breakthrough technology Intravail absorption enhancement technology which would improve the bioavailability of drugs that are delivered through the nose It has solubility enhancement effects similar to that in solid dosage formsThe technology being applied to a pill for the first time the formulation has enhanced...
IntroductionThe global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma companies were shut dow
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster